Señales en vivo de 4551.T | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 02:15):

Stats
Volumen de hoy	48 200.00
Volumen promedio	31 521.00
Capitalización de mercado	108.35B
EPS	¥0 ( 2024-04-25 )
Last Dividend	¥50.00 ( 2023-06-29 )
Next Dividend	¥0 ( N/A )
P/E	26.32
ATR14	¥5.18 (0.13%)

Volumen Correlación

Largo: 0.15 (neutral)

Corto: 0.40 (neutral)

Signal:(54.642) Neutral

Torii Pharmaceutical Co., Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Torii Pharmaceutical Co., Correlación - Moneda/Commodity

0.94
( very strong )

0.65
( weak )

0.86
( strong )

-0.75
( moderate negative )

-0.87
( strong negative )

Torii Pharmaceutical Co., Finanzas

Annual	2023
Ingresos:	¥54.64B
Beneficio Bruto:	¥24.57B (44.97 %)
EPS:	¥146.57

FY	2023
Ingresos:	¥54.64B
Beneficio Bruto:	¥24.57B (44.97 %)
EPS:	¥146.57

FY	2022
Ingresos:	¥48.89B
Beneficio Bruto:	¥23.38B (47.81 %)
EPS:	¥140.38

FY	2021
Ingresos:	¥46.99B
Beneficio Bruto:	¥24.34B (51.80 %)
EPS:	¥32.16

Financial Reports:

No articles found.

Torii Pharmaceutical Co., Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥76.00 (N/A)	¥0 (N/A)	¥50.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Torii Pharmaceutical Co., Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 7.39 - good (73.87%) | Divividend Growth Potential Score: 3.44 - Decrease likely (31.16%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥2.00	2001-03-27
Last Dividend	¥50.00	2023-06-29
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	47	--
Total Paid Out	¥907.00	--
Avg. Dividend % Per Year	0.00%	--
Score	3.09	--
Div. Sustainability Score	7.39
Div.Growth Potential Score	3.44
Div. Directional Score	5.41	--

Next Divdend (Est)
(2024-09-25)

¥0 Estimate 3.76 %

Dividend Stability

0.30 Poor

Dividend Score

3.09

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8154.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7513.T	Ex Dividend Junior	2023-08-30	Sporadic	0.00%
6741.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
6082.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
4763.T	Ex Dividend Junior	2024-02-28	Annually	0.00%
4004.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
3202.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
2208.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9069.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7956.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0939	1.500	8.12	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0398	1.200	8.67	10.00	[0 - 0.3]
returnOnEquityTTM	0.0444	1.500	-0.618	-0.927	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	6.50	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	5.20	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.280	1.500	9.56	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	32.66	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	32.66	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.448	1.000	5.86	5.86	[0.2 - 0.8]
operatingProfitMarginTTM	0.122	1.000	9.56	9.56	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.423	0.800	-0.511	-0.409	[0.5 - 2]
Total Score				7.39

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	20.50	1.000	8.03	0	[1 - 100]
returnOnEquityTTM	0.0444	2.50	-0.397	-0.927	[0.1 - 1.5]
freeCashFlowPerShareTTM	32.66	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	3.11	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	32.66	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.448	1.500	-0.349	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0163	1.000	-2.09	0	[0.1 - 0.5]
Total Score				3.44

Torii Pharmaceutical Co.,

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.